A patient-centered look at anxiety, distress, treatment burden, referral gaps, and what can make emotional support easier to find throughout cancer care.
Audience: Cancer Patients
Countries: 6
Completion Rate: 68.1%
SGID: 9017382
-Hero findings
– Quick Read — Key Findings
The survey captures people who were in active treatment, had recently completed treatment, or were receiving maintenance treatment or follow-up care.
That mix matters because emotional needs do not begin and end at one milestone: worry can start at diagnosis, intensify during treatment, return while waiting for results or change in follow-up. In this survey 43.9% were in maintenance or follow-up care, 33.3% currently in treatment and 22.7% had recently completed treatment, so the data reflects several parts of the journey, and the strongest signal is not simply that distress exists but that people may need to recognize it, raise it themselves, find the right support and sustain it while managing appointments, side effects, uncertainty and everyday life.
61.5% selected anxiety, fear, or persistent worry as the emotional challenge that affected them most after diagnosis.
Anxiety, fear or worry is the emotional challenge affecting patients most after diagnosis at 61.5%, far ahead of sleep problems or stress (20.0%), low mood (13.8%) and isolation (4.6%). Anxiety is not one thing, it may be fear about whether treatment will work, worry before scans, uncertainty about side effects or the strain of waiting, so support needs can shift even when the treatment plan looks stable.
44.6% said they were the person who first raised their emotional concerns.
Most often, emotional distress was first identified because patients raised it themselves (44.6%), ahead of routine clinic screening (26.2%), no assessment offered (15.4%) and a clinician or caregiver noticing (13.8%). The NCI frames screening as a way to find people needing fuller psychosocial assessment, and the patient-side signal is clear: when the system does not identify distress first, patients may have to start that conversation themselves.
41.5% said a support group or peer program was the first emotional support offered.
Support-group or peer help is the first emotional support most often offered at 41.5%, ahead of medication for anxiety or depression (26.2%), no formal support (16.9%) and psycho-oncology counseling (15.4%). The picture is variety rather than a single best route: the right next step may depend on the type and severity of distress, patient preference, available services and how emotional needs relate to ongoing cancer treatment.
38.5% said treatment burden made it difficult to access the emotional support they received or needed.
Treatment burden is the biggest limit on emotional support at 38.5%, ahead of support that did not match needs (24.6%), no suitable support available (21.5%) and support offered too late (15.4%). That is a practical problem: cancer care already involves travel, waiting, tests, side effects and fatigue, so a separate emotional-support pathway can add another task at exactly the moment a patient has least capacity for one.
32.3% said recurrence or prognosis concerns affected their mental health most.
Fear of recurrence or prognosis is the cancer-related issue affecting mental health most at 32.3%, with treatment side effects or fatigue and pain or physical limitations each at 27.7% and body image or sexual health at 12.3%. Emotional care cannot be separated cleanly from the physical journey: fear about the future, fatigue, pain and bodily change all affect how a person feels, and the main concern can shift over time.
35.4% selected automatic referral after distress screening as the care model that could most improve emotional support.
Automatic referral after distress screening is the care model patients most often favor at 35.4%, ahead of embedded psycho-oncology (26.2%), digital therapy between visits (20.0%) and trained peer navigators (18.5%). These solve different problems: automatic referral reduces the burden on the patient to find the next step, embedded psycho-oncology makes support feel part of cancer care, digital therapy eases travel and scheduling, and peer navigation helps people understand what support exists.
Cancer can change quickly, from diagnosis to treatment to follow-up and from stability to new uncertainty, and the emotional experience changes with it. The survey shows anxiety and fear are common but the route to help is not always automatic: many patients had to raise concerns themselves, and treatment burden or unclear referral pathways can make professional support harder to reach.
The larger story is not that every patient needs the same mental-health care, but that no one should have to navigate emotional distress alone while managing cancer. Screening helps identify needs but only matters if it leads somewhere; peer support can be valuable but may not be enough for everyone; and specialist care helps only when it is available at the right time and in a form the patient can use.
You have read the summary
Discover the complete research behind these insights, or become part of future studies with MDForLives.
Direct answers to common questions about cancer-related distress, psycho-oncology, and finding support.
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
